These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 15662229
1. Dual angiotensin-converting enzyme/neutral endopeptidase inhibition on cardiac and renal fibrosis and inflammation in DOCA-salt hypertensive rats. Pu Q, Amiri F, Gannon P, Schiffrin EL. J Hypertens; 2005 Feb; 23(2):401-9. PubMed ID: 15662229 [Abstract] [Full Text] [Related]
2. Comparison of angiotensin-converting enzyme (ACE), neutral endopeptidase (NEP) and dual ACE/NEP inhibition on blood pressure and resistance arteries of deoxycorticosterone acetate-salt hypertensive rats. Pu Q, Touyz RM, Schiffrin EL. J Hypertens; 2002 May; 20(5):899-907. PubMed ID: 12011651 [Abstract] [Full Text] [Related]
3. The potential advantage of omapatrilat: dual anti-fibrotic and anti-inflammatory effects in one single molecule. Perlini S. J Hypertens; 2005 Feb; 23(2):273-5. PubMed ID: 15662213 [No Abstract] [Full Text] [Related]
7. Effects of omapatrilat in low, normal, and high renin experimental hypertension. Trippodo NC, Robl JA, Asaad MM, Fox M, Panchal BC, Schaeffer TR. Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878 [Abstract] [Full Text] [Related]
8. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats. Pu Q, Larouche I, Schiffrin EL. Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331 [Abstract] [Full Text] [Related]
12. Dual ECE/NEP inhibition on cardiac and neurohumoral function during the transition from hypertrophy to heart failure in rats. Emoto N, Raharjo SB, Isaka D, Masuda S, Adiarto S, Jeng AY, Yokoyama M. Hypertension; 2005 Jun; 45(6):1145-52. PubMed ID: 15897363 [Abstract] [Full Text] [Related]
13. Vasopeptidase inhibition: a new concept in blood pressure management. Burnett JC. J Hypertens Suppl; 1999 Feb; 17(1):S37-43. PubMed ID: 10340842 [Abstract] [Full Text] [Related]
14. Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure. Trippodo NC, Robl JA, Asaad MM, Bird JE, Panchal BC, Schaeffer TR, Fox M, Giancarli MR, Cheung HS. J Pharmacol Exp Ther; 1995 Nov; 275(2):745-52. PubMed ID: 7473162 [Abstract] [Full Text] [Related]
15. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat. Hegde LG, Yu C, Renner T, Thibodeaux H, Armstrong SR, Park T, Cheruvu M, Olsufka R, Sandvik ER, Lane CE, Budman J, Hill CM, Klein U, Hegde SS. J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495 [Abstract] [Full Text] [Related]